How Alphatec, NuVasive & more performed in Q3: 11 device company notes

Written by Eric Oliver | November 06, 2019 | Print  |

Here are 11 key notes on spine and orthopedic device companies:

Alphatec posted a quarterly loss of $0.22 per share but increased revenues to $29.2 million. Read more

NuVasive posted $290.8 million in total revenue for the third quarter, an increase of 7.2 percent year over year. Read more

Conformis reported $17.3 million for third-quarter total revenue, down 40 percent for the same period last year. Read more

Zimmer Biomet reported a net sales increase during the third quarter of 2019. Read more

Smith+Nephew reported 6.5 percent revenue growth in the third quarter. Read more

Conmed posted third-quarter 2019 sales of $233.6 million, a 15.6 percent year-over-year increase. Read more.

Nevro received FDA approval for the Senza Omnia device, its new spinal cord stimulation system.

Nexxt Spine expanded its West Coast sales division and added a clinical specialist to educate distributor partners and surgeons on the company's spine technology.

Stryker signed a definitive agreement to acquire Wright Medical Group for $5.4 billion, which analysts believe will put the company into an antitrust lawsuit. 

The FDA granted DiFusion 510(k) clearance for its Xiphos-Zfuze spinal interbody device.

Astura Medical moved its headquarters from Carlsbad, Calif., to Irving, Texas.

More articles on devices: 
Dr. Sergiy Nesterenko opens spine clinic in Texas
California hospital adds 7 neurosurgeons to curb patient leakage
Drs. Nic Gay, Kerisimasi Reynolds team to form Silicon Valley Orthopaedics

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months